Abstract: The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.

Abstract: An apparatus includes first CPU and second CPU cores, a L1 cache subsystem coupled to the first CPU core and comprising a L1 controller, and a L2 cache subsystem coupled to the L1 cache subsystem and to the second CPU core. The L2 cache subsystem includes a L2 memory and a L2 controller configured to operate in an aliased mode in response to a value in a memory map control register being asserted. In the aliased mode, the L2 controller receives a first request from the first CPU core directed to a virtual address in the L2 memory, receives a second request from the second CPU core directed to the virtual address in the L2 memory, directs the first request to a physical address A in the L2 memory, and directs the second request to a physical address B in the L2 memory.

Abstract: This invention predicts that intra mode prediction is more effective for the macroblocks where motion estimation in inter mode prediction fails. This failure is indicated by a large value of the inter mode SAD. This invention performs intra mode prediction for only macro blocks have larger inter mode SADs. The definition of a large inter mode SAD differs for different content. This invention compares the inter mode SAD of a current macroblock with an adaptive threshold. This adaptive threshold depends on the average and variance of the SADs of the previous predicted frame. An adaptive threshold is calculated for each new predictive frame.

Abstract: In an example, a method includes executing, using one or more processors, a power-of-2 parametric activation (PACT2) function to quantize a set of data. The executing of the PACT2 function includes determining a distribution for the set of data; discarding a portion of the data corresponding to a tail of the distribution to form a remaining set of data; estimating a maximum value of the remaining set of data; determining a new maximum value of the remaining set of data using a moving average and at least one historical value of at least one prior remaining set of data; determining a clipping value by expanding the new maximum value to a nearest power of two value; and quantizing the set of data using the clipping value to form a quantized set of data.

Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Abstract: Techniques for executing machine learning (ML) models including receiving an indication to run an ML model on a processing core; receiving a static memory allocation for running the ML model on the processing core; determining that a layer of the ML model uses more memory than the static memory allocated; transmitting, to a shared memory, a memory request for blocks of the shared memory; receiving an allocation of the requested blocks; running the layer of the ML model using the static memory and the range of memory addresses; and outputting results of running the layer of the ML model.

Abstract: In described examples of a method for quantizing data for a convolutional neural network (CNN) is provided. A set of data is received and quantized the using a power-of-2 parametric activation (PACT2) function. The PACT2 function arranges the set of data as a histogram and discards a portion of the data corresponding to a tail of the histogram to form a remaining set of data. A clipping value is determined by expanding the remaining set of data to a nearest power of two value. The set of data is then quantized using the clipping value. With PACT2, a model can be quantized either using post training quantization or using quantization aware training. PACT2 helps a quantized model to achieve close accuracy compared to the corresponding floating-point model.

Abstract: An apparatus includes first CPU and second CPU cores, a L1 cache subsystem coupled to the first CPU core and comprising a L1 controller, and a L2 cache subsystem coupled to the L1 cache subsystem and to the second CPU core. The L2 cache subsystem includes a L2 memory and a L2 controller configured to operate in an aliased mode in response to a value in a memory map control register being asserted. In the aliased mode, the L2 controller receives a first request from the first CPU core directed to a virtual address in the L2 memory, receives a second request from the second CPU core directed to the virtual address in the L2 memory, directs the first request to a physical address A in the L2 memory, and directs the second request to a physical address B in the L2 memory.

Abstract: Techniques for executing machine learning (ML) models including receiving an indication to run an ML model on a processing core; receiving a static memory allocation for running the ML model on the processing core; determining that a layer of the ML model uses more memory than the static memory allocated; transmitting, to a shared memory, a memory request for blocks of the shared memory; receiving an allocation of the requested blocks; running the layer of the ML model using the static memory and the range of memory addresses; and outputting results of running the layer of the ML model.

Abstract: The present invention relates to stable pharmaceutical compositions for parenteral administration comprising aprepitant. The present invention further relates to a method for manufacturing the composition as well as to the use of these compositions. Also included are stable pharmaceutical compositions for parenteral administration comprising aprepitant and palonosetron. The pharmaceutical compositions are stable oil-in-water emulsions for parenteral administration and are particularly useful for the prevention and control of acute and delayed chemotherapy-induced nausea and vomiting (CINV), for the prevention of postoperative nausea and vomiting (PONV), and/or for the prevention of radiation induced nausea and vomiting (RINV).

Abstract: A method for sparse optical flow based tracking in a computer vision system is provided that includes detecting feature points in a frame captured by a monocular camera in the computer vision system to generate a plurality of detected feature points, generating a binary image indicating locations of the detected feature points with a bit value of one, wherein all other locations in the binary image have a bit value of zero, generating another binary image indicating neighborhoods of currently tracked points, wherein locations of the neighborhoods in the binary image have a bit value of zero and all other locations in the binary image have a bit value of one, and performing a binary AND of the two binary images to generate another binary image, wherein locations in the binary image having a bit value of one indicate new feature points detected in the frame.

Abstract: The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.

Abstract: Systems and methods can advantageously provide deauthentication/disassociation frames A method includes providing, by a first device, a disassociation frame or a deauthentication frame on a first primary control channel in response to an indication of a change from the first primary control channel to a second primary control channel, and receiving, by the first device, a data frame from a second network device on the first control primary channel, the second primary control channel or a secondary channel. The method also includes providing, by the first device, another disassociation frame or deauthentication frame on the first primary control channel, the second primary control channel and/or the secondary channel associated with the data frame.

Abstract: A cooling tower for evaporative cooling of water is contained within an ISO-compliant shipping container frame, permitting stacking of cooling towers for transport and for certain industrial applications. A volume of fill media is contained within the frame. Spaced apart troughs underlie the fill media, running substantially the length of the fill media and connecting to a basin. Baffles are connected to one upper edge of the troughs, while an air flow space is positioned over the other upper trough edge. A water distribution system, with variable flow nozzles positioned closely above the fill media, sprays water over the upper surface of the fill media, where it moves by gravity down into the troughs. Fans atop the fill media move air vertically upward through the fill media.

Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Abstract: A hardware accelerator is configured to perform matrix multiplication and/or additional operations to optimize keypoint matching. A sum of squared error (SSE) calculation may be determined by utilizing the hardware accelerator to perform matrix multiplication to obtain a cost matrix for two sets of keypoint descriptors from two images. The hardware accelerator may determine a best cost calculation for each keypoint in each direction, which is utilized to perform keypoint matching.

Abstract: A method for sparse optical flow based tracking in a computer vision system is provided that includes detecting feature points in a frame captured by a monocular camera in the computer vision system to generate a plurality of detected feature points, generating a binary image indicating locations of the detected feature points with a bit value of one, wherein all other locations in the binary image have a bit value of zero, generating another binary image indicating neighborhoods of currently tracked points, wherein locations of the neighborhoods in the binary image have a bit value of zero and all other locations in the binary image have a bit value of one, and performing a binary AND of the two binary images to generate another binary image, wherein locations in the binary image having a bit value of one indicate new feature points detected in the frame.

Abstract: A method for convolution in a convolutional neural network (CNN) is provided that includes accessing a coefficient value of a filter corresponding to an input feature map of a convolution layer of the CNN, and performing a block multiply accumulation operation on a block of data elements of the input feature map, the block of data elements corresponding to the coefficient value, wherein, for each data element of the block of data elements, a value of the data element is multiplied by the coefficient value and a result of the multiply is added to a corresponding data element in a corresponding output block of data elements comprised in an output feature map.

Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Abstract: Several methods and systems for facilitating multimedia data encoding are disclosed. In an embodiment, a plurality of picture buffers associated with multimedia data are received in an order of capture associated with the plurality of picture buffers. Buffer information is configured for each picture buffer from among the plurality of picture buffers comprising at least one of a metadata associated with the corresponding picture buffer and one or more encoding parameters for the corresponding picture buffer. A provision of picture buffers in an order of encoding is facilitated based on the configured buffer information.